Cover Image
市場調查報告書

Neos Therapeutics, Inc.的產品平台分析

Neos Therapeutics, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 317369
出版日期 內容資訊 英文 30 Pages
訂單完成後即時交付
價格
Back to Top
Neos Therapeutics, Inc.的產品平台分析 Neos Therapeutics, Inc. - Product Pipeline Review - 2015
出版日期: 2015年07月22日 內容資訊: 英文 30 Pages
簡介

Neos Therapeutics, Inc.是總公司位於美國的口服藥物遞輸企業,提供控制釋放型的口溶錠和液體藥等藥物遞輸產品,以及針對處方藥市場及消費者保健市場的受託製造服務。

本報告提供Neos Therapeutics, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Neos Therapeutics, Inc.的基本資料

  • Neos Therapeutics, Inc.概要
  • 主要資訊
  • 企業資料

Neos Therapeutics, Inc.:R&D概要

  • 主要的治療範圍

Neos Therapeutics, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Neos Therapeutics, Inc.:開發中產品概況

  • 後期階段產品開發中產品
    • 新藥登記前階段的產品/聯合治療模式
    • 第三階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 臨床試驗前階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式
  • 開發階段不明的開發中產品
    • 開發階段不明的產品/聯合治療模式

Neos Therapeutics, Inc.:藥物簡介

  • amfetamine XR
  • methylphenidate hydrochloride XR
  • Small Molecule for Cough and Cold
  • Small Molecule for Central Nervous System Disorders
  • Small Molecule for CNS Diseases
  • Small Molecule for Pain
  • Small Molecule for ADHD

Neos Therapeutics, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

最新的開發平台資訊

Neos Therapeutics, Inc.:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07294CDB

Summary

Global Markets Direct's, 'Neos Therapeutics, Inc. - Product Pipeline Review - 2015', provides an overview of the Neos Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Neos Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Neos Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Neos Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Neos Therapeutics, Inc.'s pipeline products

Reasons to buy

  • Evaluate Neos Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Neos Therapeutics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Neos Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Neos Therapeutics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Neos Therapeutics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Neos Therapeutics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Neos Therapeutics, Inc. Snapshot
    • Neos Therapeutics, Inc. Overview
    • Key Information
    • Key Facts
  • Neos Therapeutics, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Neos Therapeutics, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Neos Therapeutics, Inc. - Pipeline Products Glance
    • Neos Therapeutics, Inc. - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Filing rejected/Withdrawn Products/Combination Treatment Modalities
    • Neos Therapeutics, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
    • Neos Therapeutics, Inc. - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Neos Therapeutics, Inc. - Drug Profiles
    • methylphenidate hydrochloride XR
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • amfetamine XR
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Cough and Cold
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Central Nervous System Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for CNS Diseases
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Pain
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for ADHD
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Neos Therapeutics, Inc. - Pipeline Analysis
    • Neos Therapeutics, Inc. - Pipeline Products by Target
    • Neos Therapeutics, Inc. - Pipeline Products by Route of Administration
    • Neos Therapeutics, Inc. - Pipeline Products by Molecule Type
    • Neos Therapeutics, Inc. - Pipeline Products by Mechanism of Action
  • Neos Therapeutics, Inc. - Recent Pipeline Updates
  • Neos Therapeutics, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Neos Therapeutics, Inc., Key Information
  • Neos Therapeutics, Inc., Key Facts
  • Neos Therapeutics, Inc. - Pipeline by Indication, 2015
  • Neos Therapeutics, Inc. - Pipeline by Stage of Development, 2015
  • Neos Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
  • Neos Therapeutics, Inc. - Pre-Registration, 2015
  • Neos Therapeutics, Inc. - Filing rejected/Withdrawn, 2015
  • Neos Therapeutics, Inc. - Preclinical, 2015
  • Neos Therapeutics, Inc. - Discovery, 2015
  • Neos Therapeutics, Inc. - Unknown, 2015
  • Neos Therapeutics, Inc. - Pipeline by Target, 2015
  • Neos Therapeutics, Inc. - Pipeline by Route of Administration, 2015
  • Neos Therapeutics, Inc. - Pipeline by Molecule Type, 2015
  • Neos Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Neos Therapeutics, Inc. - Recent Pipeline Updates, 2015

List of Figures

  • Neos Therapeutics, Inc. - Pipeline by Top 10 Indication, 2015
  • Neos Therapeutics, Inc. - Pipeline by Stage of Development, 2015
  • Neos Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
  • Neos Therapeutics, Inc. - Pipeline by Top 10 Target, 2015
  • Neos Therapeutics, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Neos Therapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Neos Therapeutics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top